Feinstein Partners, Inc.


Oct 07, 08

NEW STORY
05:00 ET Monogram Reaffirms Guidance for Year and Provides Update on Oncology Programs

 
Oct 03, 08

16:30 ET Monogram Receives NASDAQ Notification

 
Oct 01, 08

07:30 ET Gene Network Sciences Announces Drug Development Collaboration with Biogen Idec

 
Sep 29, 08

13:25 ET Monogram Biosciences to Present at the JMP Securities Healthcare Conference

 
Sep 23, 08

07:00 ET Monogram and Dana-Farber Cancer Institute Initiate Evaluation of HERmark(TM) Breast Cancer Assay in Metastatic Breast Cancer

 
Sep 19, 08

10:48 ET Academy Award Winner Louis Gossett Jr. Joins Tens of Thousands of Americans Rallying in 80 Communities, Celebrating Recovery from Addiction

 
Sep 18, 08

08:00 ET IDIS to Sponsor Inaugural Conference on Pre-Launch Access to Drugs

 
Sep 17, 08

08:00 ET Tethys Bioscience Announces Acquisition of Lipomics Technologies

 
Sep 15, 08

06:00 ET Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer

 
Aug 26, 08

07:00 ET IDIS Opens New American Office in Response to Industry's Growing Need for Pre-Launch Named Patient Programs

 
Aug 25, 08

12:12 ET First Major Medical Meeting Convening for MRI-guided Focused Ultrasound to Treat Cancer, Stroke, Fibroids, Other Conditions

 
Aug 21, 08

09:00 ET Monogram Appoints Oncologist to Board of Directors

 
Aug 20, 08

09:00 ET Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc.

 
08:45 ET Alzheimer's Disease and Emerging Treatments Analyzed in Neurotech Insights

 
Aug 13, 08

09:58 ET John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technology's Potential to Help 'Millions of Patients'

 
Aug 11, 08

08:02 ET InterWest Partners Announces Closing of $650 Million Venture Fund

 
Aug 07, 08

15:12 ET Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008

 
14:30 ET Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads

 
13:30 ET Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients

 
Aug 06, 08

13:05 ET Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy

 
Aug 04, 08

08:30 ET Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors

 
Jul 29, 08

15:49 ET Monogram Announces 2008 Second Quarter Financial Results

 
Jul 23, 08

06:00 ET Monogram Announces Issuance of Key Patents Related to VeraTag(TM) Technology

 
Jul 16, 08

13:15 ET Monogram Biosciences Announces Second Quarter 2008 Financial Results Conference Call

 
Jul 08, 08

08:00 ET Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day

 
04:00 ET Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay

 
Jul 01, 08

06:00 ET Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference

 
Jun 18, 08

06:00 ET Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies

 
Jun 17, 08

05:07 ET Organizing Tips for the ADHD Family

 
Jun 16, 08

06:00 ET Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy

 
Jun 07, 08

13:09 ET Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test

 
Jun 05, 08

06:00 ET Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay

 
Jun 02, 08

14:45 ET Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting

 
May 29, 08

09:00 ET Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning

 
May 20, 08

10:45 ET Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

 
10:45 ET Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation

 
09:15 ET Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients

 
May 16, 08

12:02 ET Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting

 
09:31 ET Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008

 
May 08, 08

07:00 ET Neurotechnology Industry Reports Record Global Growth of $130.5 Billion in 2007

 
May 07, 08

15:26 ET Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain-Related Illness

 
May 01, 08

16:11 ET HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics

 
16:00 ET Monogram Announces 2008 First Quarter Financial Results

 
Apr 21, 08

13:30 ET Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call

 
Apr 15, 08

16:45 ET FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment

 
Apr 14, 08

21:30 ET Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference

 
Apr 08, 08

06:04 ET Navigenics Proposes Standards for Personal Genomics Services, Coupled With Prospective Outcomes Studies, to Safeguard Consumers

 
06:02 ET Navigenics'(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments

 
06:00 ET Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health

 
06:00 ET New York Medicaid Program Establishes Coverage for Trofile(TM)

 
Apr 07, 08

06:00 ET Prestigious Scientific Leaders Join InterWest Advisory Committee

 
Apr 01, 08

06:00 ET Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials

 
Mar 31, 08

06:00 ET Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program

 
Mar 25, 08

06:00 ET Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology

 
Mar 19, 08

06:00 ET Stephen Holmes of InterWest Appointed to Prestigious Venture Capital Valuation Board

 
Mar 17, 08

02:00 ET California Medicaid Establishes Coverage for Trofile(TM)

 
Mar 10, 08

09:00 ET Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts

 
Feb 11, 08

10:01 ET Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008

 
Feb 07, 08

16:00 ET Monogram Announces 2007 Year-End Financial Results

 
06:00 ET Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity

 
Feb 04, 08

06:00 ET DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use

 
Jan 30, 08

19:39 ET Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call

 
Jan 09, 08

14:52 ET Dey, L.P. Settles State of Alabama Pricing Litigation

 
Dec 19, 07

16:00 ET Study Reaffirms Superiority of Trofile(TM) Assay

 
Dec 14, 07

08:00 ET HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium

 
Dec 10, 07

06:00 ET Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium

 
Nov 29, 07

08:30 ET Dr. Ralph Snyderman, Chancellor Emeritus, Duke University, and Founder and Chairman of Proventys, Inc., Receives 2007 Leadership in Personalized Medicine Award

 
Nov 28, 07

08:00 ET Dey, L.P. Partners with COPD Foundation in Support of National Heart, Lung and Blood Institute (NHLBI)'s COPD Learn More Breathe Better Awareness Campaign

 
Nov 08, 07

13:49 ET Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference

 
13:36 ET Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference

 
Nov 07, 07

07:00 ET Monogram Obtains Coverage for Trofile(TM) Assay from California ADAP Program

 
Nov 06, 07

06:00 ET Navigenics Launches With Preeminent Team of Advisers, Partners and Investors

 
Nov 02, 07

07:00 ET Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007

 
Oct 24, 07

16:01 ET Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD

 
16:01 ET Two Clinical Trials for Nebulized Formoterol Fumarate on Long-Term and Cardiovascular Safety in Treating COPD

 
16:00 ET Monogram Announces Third Quarter 2007 Financial Results

 
Oct 17, 07

17:15 ET Monogram Biosciences Announces Third Quarter 2007 Financial Results Conference Call

 
Oct 16, 07

08:30 ET Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007

 
Oct 12, 07

17:31 ET FDA Approves Administration of LEXIVA(R) with Lower Dose of 'Boosting' Medication Ritonavir

 
Oct 10, 07

13:10 ET Monogram Biosciences to Present at the JMP Securities Healthcare Conference

 
Oct 08, 07

07:30 ET Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD

 
Oct 01, 07

07:00 ET Pfizer Receives E.U. Approval of Maraviroc; Monogram Initiates European Operations

 
Sep 27, 07

09:12 ET Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma

 
Sep 24, 07

07:00 ET Monogram Announces First Medicare Payment for Trofile(TM)

 
Sep 21, 07

08:00 ET Trial Date Set for Patent Infringement Suit Against Sepracor's Brovana(TM)

 
Sep 19, 07

07:00 ET Leading Policymakers, Scientists, Industry Executives Discuss Implementation of Evidence-Based, Personalized Medicine

 
07:00 ET Studies Highlight Superior Performance of Trofile(TM) Assay

 
Sep 18, 07

12:10 ET Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay

 
08:30 ET Personalized, Online Help for Prescription Painkiller and Heroin Dependence: Confidential Treatment in a Doctor's Private Office

 
Sep 12, 07

12:12 ET Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults

 
11:10 ET Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month

 
10:38 ET Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide

 
Sep 07, 07

13:15 ET Monogram Biosciences to Present at the ThinkEquity Partners' Fifth Annual Growth Conference

 
Sep 05, 07

07:00 ET Medicare Contractor Establishes Reimbursement Coding Guidance for Monogram's Trofile Assay

 
Aug 27, 07

14:06 ET Joint NJ/NY Rally for Addiction Recovery to be Hub of Events Nationwide

 
Aug 23, 07

07:00 ET Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007

 
Aug 13, 07

08:49 ET Introducing Addiction411: Online Tool to Educate the MySpace Generation about Opioid Addiction

 
Aug 10, 07

08:00 ET Introducing Addiction411: Online Tool to Educate the MySpace Generation About Opioid Addiction

 
Aug 06, 07

18:32 ET Monogram Biosciences Announces Conference Call to Discuss Commercial Introduction of Trofile(TM) Assay

 
13:05 ET Monogram Announces Commercial Introduction of Trofile(TM) Assay

 
Jul 26, 07

16:00 ET Monogram Announces Second Quarter 2007 Financial Results

 
Jul 25, 07

07:00 ET New Head-to-Head Study Comparing LEXIVA(R) and Atazanavir Show Similar Efficacy and Lipid Changes

 
06:00 ET Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show

 
Jul 20, 07

18:07 ET Monogram Biosciences Announces Second Quarter 2007 Financial Results Conference Call

 
06:00 ET European Committee Issues Positive Opinion of Pfizer's Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1

 
Jul 09, 07

01:15 ET Exelon(R)Patch, the First and Only Skin Patch for the Treatment of Alzheimer's Disease, Receives First Worldwide Approval in US

 
Jun 25, 07

07:00 ET Monogram Biosciences to Present at The C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

 
Jun 23, 07

11:00 ET Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset(TM) (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes

 
Jun 20, 07

18:00 ET Monogram Provides Update on Trofile(TM) Assay

 
Jun 18, 07

18:31 ET Medi-Cal Expands Coverage of Baseline HIV Resistance Testing

 
08:00 ET VeroScience Late-Breaking Abstract on Cycloset(TM) (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions

 
Jun 04, 07

06:00 ET GlaxoSmithKline Launches Educational Campaign in Detroit to Address 'Silent Epidemic' of Genital Herpes Among African American Adults

 
May 31, 07

09:38 ET FDA Approves ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Critical Therapeutics, DEY Marketing Partner for Chronic Treatment of Asthma

 
07:00 ET Monogram Presents Results of First eTag Breast Cancer Studies

 
May 30, 07

10:00 ET BioBank Central Launches Online Forum to Drive Global Connectivity Among Biobanking Community

 
May 21, 07

08:00 ET Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

 
May 20, 07

13:45 ET Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

 
May 17, 07

11:00 ET Neurotechnology Industry Report Says Revenues Grew 10% to $120.5 Billion in 2006; U.S. Economic Impact of Brain-related Illness Reached $1 Trillion

 
May 16, 07

16:35 ET Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2007

 
May 11, 07

14:25 ET FDA Approves Dey, L.P.'s Perforomist(TM) (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD

 
May 07, 07

08:00 ET Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies

 
May 02, 07

16:00 ET Monogram Announces First Quarter 2007 Financial Results

 
Apr 26, 07

17:10 ET Monogram Announces Conference Call

 
Apr 25, 07

07:30 ET Community Anti-Drug Coalitions Across Tennessee (CADCAT) to Host Public Forum on Substance Abuse Prevention, Treatment and Recovery

 
Apr 24, 07

20:24 ET FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1

 
14:27 ET Dey, L.P. Reaches Settlement with Commonwealth of Massachusetts on Pricing Litigation

 
Apr 17, 07

07:00 ET Community Anti-Drug Coalitions Across Tennessee (CADCAT) to Host Public Forum on Substance Abuse Prevention, Treatment and Recovery

 
Mar 29, 07

14:01 ET Dey, L.P. Reaches Settlement with State of Nevada on Pricing Litigation

 
10:00 ET Neurotechnology Executives Tap Political Leaders to Help Patients With Brain- Related Illnesses

 
Mar 23, 07

13:24 ET Personalized Medicine Coalition Announces Support for Secretary Leavitt's Personalized Health Care Initiative

 
Mar 21, 07

17:12 ET Dey, L.P. Reaches Settlement with State of Hawaii on Pricing Litigation

 
Mar 15, 07

11:59 ET Message Carriers To Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'

 
Mar 13, 07

07:00 ET Atlanta to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'

 
Mar 09, 07

05:00 ET U.S. Court of Appeals Reinstates Permanent Injunction Against Abbott Laboratories for Infringing Innogenetics' Patent

 
Mar 08, 07

10:29 ET Atlanta to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'

 
Mar 07, 07

15:11 ET Hartford's HBO ADDICTION Premier draws recovery advocates, community leaders and people in recovery to support recovery from alcohol and other drug addiction

 
11:00 ET The Alliance for Recovery to Showcase HBO's New Documentary ADDICTION for Local Media and Treatment Professionals

 
Mar 06, 07

10:11 ET The Alliance for Recovery to Showcase HBO's New Documentary ADDICTION for Local Media and Treatment Professionals

 
Mar 05, 07

07:00 ET The Miami Coalition, The Hispanic Crime Prevention Program, Center for Administration of Justice, Florida International University and The F.I.U. Community-Based Intervention Research Group to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting

 
06:00 ET Scientific Data Highlights Pivotal Role of Monogram's Molecular Diagnostics in Development and Use of New HIV Treatments

 
Mar 02, 07

07:00 ET San Antonio Fighting Back, Inc. to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'

 
Mar 01, 07

15:06 ET Monogram Provides Update on Trofile(TM) Assay - Pfizer Reports Significant Reduction in Viral Load in Clinical Trial of Maraviroc

 
Feb 27, 07

09:43 ET San Antonio Fighting Back, Inc. to Showcase HBO's New Documentary ADDICTION at 'Town Hall Meeting'

 
Feb 13, 07

07:18 ET Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay

 
Feb 08, 07

16:00 ET Monogram Announces Year-End 2006 Financial Results

 
Feb 05, 07

13:38 ET Monogram Biosciences Announces Fourth Quarter 2006 Financial Results Conference Call

 
Jan 17, 07

13:48 ET Personalized Medicine Coalition Supports President Bush's Call to Congress to Pass the Genetic Information Nondiscrimination Act

 
Jan 12, 07

07:00 ET Monogram Biosciences Prices Private Placement of Convertible Senior Unsecured Notes

 
Jan 11, 07

03:02 ET Court Permanently Halts Abbott's Sale of HCV Genotyping Products for Infringing Innogenetics' Patent

 
Jan 04, 07

12:43 ET Genomas Announces Physiogenomic Study That Reveals Potential Cause of Metabolic Side Effects in Patients Treated With Psychotropic Drugs

 
03:22 ET Court Affirms $7 Million in Damages for Innogenetics in Patent Infringement Suit

 
Jan 02, 07

14:24 ET Monogram Biosciences To Present at the 25th Annual JPMorgan Healthcare Conference

 
Dec 29, 06

15:44 ET Levin Amendment Expands Access to 'Miracle Drug' to Treat Heroin Addiction

 
13:04 ET Bush Signs Law: More Patients May be Treated for Opioid Dependence/Addiction with Buprenorphine

 
Dec 11, 06

09:56 ET Congress Passes Legislation Increasing Treatment for Opioid Dependence/Addiction using Buprenorphine

 
Dec 08, 06

09:00 ET UCSF Pharmacy School Receives Major Grant From Amgen Foundation For Medicare Part D Outreach

 
Dec 01, 06

06:00 ET Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay

 
Nov 28, 06

12:17 ET Dey, L.P. Reaches Settlement with State of Ohio on Pricing Litigation

 
10:12 ET Dr. Elizabeth G. Nabel, Director of the National Heart, Lung, and Blood Institute, Receives 2006 Leadership in Personalized Medicine Award

 
Nov 21, 06

06:00 ET Monogram Biosciences to Present at Personalized Medicine: A World of Opportunities

 
Nov 20, 06

06:00 ET Monogram Biosciences to Present at the Lazard Capital Markets Third Annual Life Sciences Conference

 
Nov 14, 06

15:47 ET Dey, L.P. Reaches Settlement with State of Idaho on Pricing Litigation

 
12:00 ET New Report Cites Emerging Impact of Personalized Medicine on Healthcare

 
Nov 13, 06

14:00 ET SyntheMed Announces Listing on Frankfurt Stock Exchange

 
Oct 30, 06

08:30 ET SyntheMed to Present at 8th Annual Rodman and Renshaw Healthcare Conference

 
Oct 26, 06

16:03 ET Monogram Announces Third Quarter 2006 Financial Results

 
Oct 23, 06

19:57 ET Monogram Biosciences Announces Third Quarter 2006 Financial Results Conference Call

 
08:30 ET SyntheMed to Present at the C.E. Unterberg, Towbin Life Sciences Conference

 
Oct 16, 06

20:36 ET Monogram Biosciences to Present at the BIO Investor Forum 2006

 
Oct 13, 06

08:30 ET SyntheMed Incorporated to Present at BIO InvestorForum 2006

 
Oct 12, 06

12:00 ET GlaxoSmithKline Sponsors HIV Medicine Association Minority Fellowship Program

 
Oct 03, 06

07:30 ET Detroit Deaths from Fentanyl-Laced Heroin Overdoses Could Be Reduced by Medical Treatment

 
06:00 ET Monogram Announces $10 Million Revolving Line of Credit

 
Sep 28, 06

17:30 ET New Data Reinforce Efficacy of TRIZIVIR(R) Alone in Treatment-Naive HIV Patients with Low Viral Load

 
17:00 ET GlaxoSmithKline and Vertex Pharmaceuticals Announce Virologic and Drug Resistance Results from Protease Inhibitor Study

 
01:15 ET New Data for FTY720 -- Aiming to Become the First Orally Effective Multiple Sclerosis Treatment -- Show Sustained Benefits Over Two Years

 
Sep 21, 06

08:30 ET Chicago Deaths from Fentanyl-Laced Heroin Overdoses Could Be Reduced by Medical Treatment

 
Sep 19, 06

07:30 ET Available Medical Treatments Could Counter Growing Prescription Painkiller Abuse Among Young Adults, Teens

 
Sep 13, 06

17:00 ET Phase II Data Showing Clinical Benefits of Novel Once-Daily Oral Multiple Sclerosis Therapy FTY720 (Fingolimod) Published in New England Journal of Medicine

 
Sep 11, 06

13:15 ET Statement from Dey, L.P. Regarding Pricing Litigation by the U.S. Department of Justice

 
07:30 ET SyntheMed Appoints John Benson as Controller

 
Sep 08, 06

22:14 ET Jury Finds Abbott Willfully Infringed Innogenetics HCV Patent

 
Sep 07, 06

07:30 ET Nationwide Service to Match Opioid-Addicted Patients with Physicians Offering Private In-Office Medical Treatment

 
Sep 06, 06

07:00 ET SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)

 
Aug 31, 06

10:14 ET Alfacell Updates Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma

 
07:00 ET Midstate Deaths from Fentanyl-Laced Heroin Overdoses Could be Reduced by Medical Treatment

 
07:00 ET Philadelphia Deaths from Fentanyl-Laced Heroin Overdoses Could be Reduced by Medical Treatment

 
Aug 23, 06

08:48 ET SyntheMed Secures CE Mark Approval for REPEL-CV(R)

 
Aug 17, 06

17:00 ET Four Studies Affirm Significance of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay

 
12:45 ET Head-to-Head Study Comparing LEXIVA(R) (fosamprenavir calcium) to Kaletra(R) Presented at IAC 2006 and Published in The Lancet

 
Aug 14, 06

08:00 ET GlaxoSmithKline and Shionogi Complete Initial Clinical Study for HIV Integrase Inhibitor

 
Aug 13, 06

11:18 ET Updated HIV Treatment Guidelines Now Include Three GSK HIV Medications for Initial Antiretroviral Treatment Regimens

 
Aug 12, 06

08:00 ET Four Studies Affirm Significance of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay

 
Jul 25, 06

07:00 ET Monogram Announces Second Quarter 2006 Financial Results

 
06:00 ET Monogram Announces Allowance of U.S. Patent Related to eTag(TM) Technology

 
Jul 21, 06

13:34 ET Monogram Biosciences Announces Second Quarter 2006 Financial Results Conference Call

 
Jul 19, 06

10:00 ET Exelon(R) Patch, the first transdermal therapy for Alzheimer's disease, may provide a promising new approach to treatment

 
Jul 05, 06

08:00 ET Monogram Biosciences to Present at the C. E. Unterberg, Towbin Emerging Growth Conference

 
Jun 27, 06

19:39 ET The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine tartrate) as the First Medication Indicated to Treat Parkinson's Disease Dementia

 
Jun 13, 06

08:30 ET Surging Heroin Addiction a Major Public Health Threat in Washington, D.C.

 
Jun 12, 06

08:00 ET Monogram Announces Settlement of CVR Liability

 
Jun 06, 06

08:00 ET Monogram Biosciences to Present at the Pacific Growth Equities' 2006 Life Sciences Growth Conference

 
May 31, 06

08:40 ET Opioid Addiction, a Major Public Health Threat in Atlanta, Often Overlooked and Untreated

 
08:38 ET Addiction to Prescription Painkillers and Heroin Surges in Pittsburgh, Most Widely Abused Drugs Citywide

 
May 26, 06

11:17 ET Monogram Announces Intention to Pay Any CVR Liability in Cash

 
May 24, 06

08:00 ET Monogram Announces Allowance of U.S. Patents for Its HIV Entry and Co-Receptor Tropism Technology

 
May 22, 06

08:00 ET Monogram Announces the Closing of Pfizer's $25 million Investment in Monogram

 
May 17, 06

17:24 ET FDA Advisory Committee Recommends Approval of Exelon(R) (rivastigmine tartrate) in the Treatment of Dementia Associated with Parkinson's Disease

 
May 08, 06

08:05 ET Monogram Announces First Quarter 2006 Financial Results

 
08:00 ET Pfizer to Invest $25 Million in Monogram

 
May 05, 06

18:14 ET Monogram Biosciences Announces First Quarter 2006 Financial Results Conference Call

 
Apr 26, 06

13:35 ET Monogram Biosciences to Present at the Deutsche Bank 31st Annual Health Care Conference

 
Apr 25, 06

16:27 ET Dey, L.P. Reaches Settlement with State of Missouri on Pricing Litigation

 
Mar 15, 06

12:19 ET TRACON Pharmaceuticals Assembles Industry-Leading Management Team to Support Development of Targeted Cancer Therapy Pipeline

 
Feb 28, 06

19:14 ET Monogram Biosciences to Present at the SG Cowen & Co. 26th Annual Health Care Conference

 
Feb 22, 06

08:03 ET Monogram Announces Year End 2005 Financial Results

 
Feb 21, 06

11:17 ET Monogram and Merck to Collaborate on Phase III Trials of Merck's Investigational HIV-1 Integrase Inhibitor

 
Feb 15, 06

18:30 ET Monogram Biosciences Announces Fourth Quarter 2005 Financial Results Conference Call

 
07:01 ET Monogram and Dana-Farber Cancer Institute Enter Collaboration Agreement

 
Feb 14, 06

08:07 ET Dey, L.P. Names Christy Taylor New SVP for Sales, Marketing and Business Development

 
Feb 09, 06

13:00 ET Data Highlighting the Role of Molecular Diagnostics Presented at Major HIV/AIDS Meeting

 
Feb 01, 06

07:03 ET National Survey Finds Nearly Half of Public Unaware Prescription Painkiller Abuse is as Harmful as Using Heroin

 
Jan 12, 06

08:00 ET More Than 900 Hospitals Sign with U.S. Surgical Under Novation Supply Agreements

 
Jan 05, 06

02:30 ET Merck KGaA Names Engle New Generics Group Regional Director, North America

    
Jan 04, 06

16:53 ET Monogram Biosciences to Present at the 24th Annual JPMorgan Healthcare Conference

 
Dec 15, 05

07:01 ET Monogram Presents Data Demonstrating Cost-Effectiveness of PhenoSense GT(TM) and Leadership in Advancing HIV Resistance Testing

 
Dec 01, 05

07:01 ET Monogram's eTag(TM) Technology Featured in British Journal of Cancer

 
Nov 30, 05

10:08 ET Number of Pills Affects Adherence to HIV Treatment Regimens

 
Nov 18, 05

09:46 ET FDA Approves Updated Labeling for GSK's LEXIVA

 
Nov 16, 05

11:49 ET World COPD Day: 12 Million Americans Unaware They Are at Risk for Fourth Leading Cause of Death

 
Nov 04, 05

08:49 ET Icagen Reports Third Quarter 2005 Financial Results

 
Nov 03, 05

08:09 ET Dr. Janet Woodcock of U.S. Food and Drug Administration to be Presented with First Leadership in Personalized Medicine Award

 
08:09 ET New Survey Shows Americans Want Genetic Information in Health Care, But Fear Privacy, Ethical, Emotional Implications

 
Nov 01, 05

17:54 ET Icagen to Present at Two Upcoming Conferences

 
Oct 27, 05

09:02 ET Icagen Announces Third Quarter 2005 Financial Results Conference Call

 
Sep 19, 05

09:00 ET Icagen to Present at the 2005 UBS Global Life Sciences Conference

 
Aug 04, 05

09:07 ET New Study Suggests Patients With Schizophrenia Improved With Treatment Change to RISPERDAL(R) CONSTA(R)

 
Aug 03, 05

12:44 ET President Bush Signs Bill Lifting Restriction on Office-Based Treatment with Buprenorphine for Opioid Dependence/Addiction

 
Jul 27, 05

14:56 ET Congress Passes Legislation to Lift Restriction on Medical Groups that Prescribe Buprenorphine for Opioid Dependence/Addiction

 
11:00 ET Patient Satisfaction With Once-Daily Dosing Of HIV Fixed-Dose Combination Tablet EPZICOM

 
Jul 26, 05

11:00 ET Epidemiology Study Reports New Information on Hypersensitivity Reactions to Abacavir

 
11:00 ET Long-Term Safety Data Of LEXIVA/R In HIV Patients Co-Infected With Hepatitis

 
Jun 16, 05

12:11 ET Many Patients With Schizophrenia Who Transitioned to RISPERDAL(R) CONSTA(R) Avoided Relapse and Experienced Symptom Improvement

 
Jun 07, 05

17:12 ET MedQuist Eliminates Use of AAMT Line Unit of Measure

 
May 27, 05

07:00 ET FDA Grants Approval to Market Focalin XR(TM) for the Treatment of ADHD in Adults, Adolescents and Children

 
Apr 28, 05

14:43 ET DEY, L.P. Donates Time and Resources to Brighten Seneca Center

 
Apr 26, 05

09:17 ET Neve Campbell Helps Launch National Program for People Living with Epilepsy

 
Apr 11, 05

09:12 ET Mass. Biotechnology Council and MassBioEd Announce $9M Major Public/Private Partnership to Advance Science Education in the State

 
Apr 08, 05

08:01 ET Sen. Kennedy, State Legislative Leaders, Mass Biotechnology Council and MassBioEd to Launch Major High School Science Education Initiative with an Event at the Statehouse

 
Apr 01, 05

09:08 ET Genzyme Corporation Becomes First Corporate Sponsor of BioTeach Program ------------------------------------------------ Makes five-year, $250,000 commitment

 
Mar 30, 05

07:05 ET Ardais(R) and Cytomyx Announce Translational Medicine Collaboration

 
Mar 22, 05

10:47 ET Personalized Medicine Coalition Supports FDA's Pharmacogenomic Data Submissions Guidance

 
Feb 25, 05

09:00 ET Ardais(R) and ATCC to Deliver Scaleable Biospecimen Management Solution for Translational Medicine

 
Feb 18, 05

08:16 ET Cyclacel & U. of Edinburgh Scientists Solve 3-D Structures of PCNA Complexes: Important Target for New Cancer Treatments

 
08:00 ET US Patent Granted to Cyclacel for Novel Cyclin Dependent Kinase Inhibitor Series

 
Feb 01, 05

08:17 ET University of Arkansas for Medical Sciences Adopts Ardais(R) Biospecimen Management System

 
Jan 26, 05

10:21 ET Stephen Elledge, Ph.D., of Harvard/Partners Center for Genetics and Genomics Receives Premier Award from Genetics Society of America

 
Jan 14, 05

12:39 ET Icagen and Abbott Renew Drug Discovery Collaboration

 
08:01 ET Napa Chamber of Commerce Names DEY, L.P. Business of the Year

 
Jan 12, 05

09:01 ET Scandius BioMedical's Stratis (TM) ST ACL Reconstruction System launched and successfully used in initial surgeries

 
Jan 03, 05

17:18 ET DEY, L.P. Donates $100,000 to the American Red Cross Tsunami Disaster Relief Effort

 
Dec 09, 04

07:01 ET New Study in the New England Journal of Medicine Shows Exelon May Help Parkinson's Disease Patients Who Suffer From Dementia

 
Dec 06, 04

17:47 ET Icagen Reports Positive Results of Phase II Clinical Trial of ICA-17043 for The Treatment of Sickle Cell Anemia

 
08:33 ET Bristol-Myers Squibb Launches ChoiceDM(TM) A1C Home Test -- First At-Home Test to Measure Long Term Blood Sugar Control

 
Nov 22, 04

09:00 ET Transport Pharmaceuticals Secures $27 Million in Venture Financing to Continue Development of Unique Drug Delivery Platform

 
Nov 19, 04

08:01 ET Chest Symposium Offers Guidance on COPD Best Clinical Practices for Inhalation Therapy, Dangers of Pharmacy Compounded Respiratory Products

 
Nov 16, 04

08:00 ET Dey, L.P. to Fund 2005 Nationwide COPD Patient Education Days Through National Emphysema/COPD Association (NECA)

 
Nov 09, 04

16:12 ET Novartis Institutes for BioMedical Research Unveils Redesigned Water Tower and Announces Educational Collaborations

    
Nov 08, 04

09:11 ET Science Selects Cyclacel Work as Editor's Choice

 
09:09 ET Beneficial Effects of Seliciclib (CYC202) Reported in Models of Kidney Disease

 
09:06 ET FDA Grants Scandius BioMedical Market Clearance for Novel Technology Designed to Simplify Common Sports-Related Surgery

 
08:07 ET Dey, L.P. Reaches Settlement with State of Arkansas on Pricing Litigation

 
Oct 27, 04

17:00 ET Novartis and the Broad Institute of MIT and Harvard Announce Unique Public/Private Collaboration to Uncover Genetic Basis for Type 2 Diabetes

 
Oct 26, 04

16:45 ET Novartis and Orion Pharma Launch First Parkinson's Disease Study to Explore Potential of Delaying Motor Complications with Stalevo (R)

 
Oct 25, 04

08:06 ET New Studies Suggest Investigational Once-Daily ADHD Treatment Is Safe and Effective in Both Children and Adults

 
Oct 21, 04

09:03 ET New Coalition Launched to Advance Personalized Medicine

 
Sep 02, 04

09:01 ET Icagen Receives Milestone Payment from McNeil Consumer & Specialty Pharmaceuticals

 
Aug 24, 04

14:05 ET Maine Medical Center Adopts Ardais(R) Biospecimen Management System

 
Aug 12, 04

07:02 ET Ardais(R) Corporation Raises Additional $4 Million to Reach Cash Flow Breakeven

 
Aug 02, 04

09:06 ET Vital Therapies, Inc. Receives Orphan Drug Designation for Key Component in Liver Assist Program

 
Jul 26, 04

07:03 ET Cyclacel Announces Postponement of Initial Public Offering

 
Jul 15, 04

09:01 ET BioTrove, Inc. Licenses Genomics Application from Stanford University for Nanotiter Plates

 
Jul 07, 04

09:31 ET New Office-Based Treatment for Prescription Drug and Heroin Addiction

 
Jul 02, 04

07:21 ET Cyclacel Announces Registration for Initial Public Offering

 
Jun 29, 04

09:00 ET Icagen and McNeil Consumer & Specialty Pharmaceuticals Enter into Development And Commercialization Agreement for Sickle Cell Disease Treatment

 
Jun 16, 04

08:32 ET Icagen Expands Senior Management Team

 
Jun 14, 04

09:01 ET Spherics, Inc. Begins Phase I Clinical Trial with Spherazole(TM), Bioadhesive-Based Itraconazole

 
Jun 07, 04

09:10 ET Spherics, Inc. Appoints Avinash Nangia, Ph.D. as Vice President of Research and Development

 
09:06 ET Researchers Present Results from Studies of Therion's Therapeutic Cancer Vaccines in Patients with Pancreatic Cancer

 
Jun 03, 04

09:03 ET BioTrove, Inc. Appoints Alan Barber as Chief Financial Officer

 
Jun 02, 04

08:33 ET RISPERDAL (R) (risperidone) Shown to Rapidly Reduce Manic Symptoms Associated With Bipolar I Disorder

 
May 25, 04

08:05 ET NECA's COPD Patient Needs Assessment Survey Presented at American Thoracic Society

 
May 24, 04

08:32 ET Therion Biologics Corporation Receives FDA Agreement to Initiate Phase III Clinical Trial With PANVAC(TM)-VF In Advanced Pancreatic Cancer

 
08:18 ET Scientists From Australia and New Zealand Discuss Stem Cell Research and Clinical Trials at 3rd Annual Conference in Cambridge, Massachusetts

 
May 19, 04

11:01 ET MorphoSys and Novartis Forge Strategic Antibody Alliance

 
May 12, 04

09:00 ET Novartis Teams Up with Parkinson's Disease Groups to Launch New Resource for the 1.5 Million People Living with Parkinson's Disease

 
May 06, 04

09:01 ET BioTrove, Inc. Appoints Michael Olex as Vice President of Manufacturing

 
May 05, 04

12:01 ET RISPERDAL(R) CONSTA(TM) IMPROVES SYMPTOM CONTROL IN MANY PEOPLE WITH SCHIZOPHRENIA

 
12:00 ET MANY STABILIZED, YOUNG ADULTS WITH SCHIZOPHRENIA MAY BENEFIT FROM EARLY TREATMENT WITH RISPERDAL(R) CONSTA(TM)

 
07:31 ET New Study Suggests Investigational ADHD Treatment is Safe and Effective in Adults

 
May 03, 04

09:04 ET 'Jubiloso/Lamentoso: An Evening of Great Music from Composers who Lived with Bipolar Disorder' Raises Awareness of a Serious Mental Illness

 
Apr 26, 04

09:05 ET BioTrove, Inc. Appoints Alan Carter as Vice President of Worldwide Sales

 
Apr 19, 04

08:08 ET Dynogen Secures $50 Million Series B Financing to Advance Its Pipeline Of Genitourinary and Gastrointestinal Development Programs

 
08:07 ET Duke University Medical Center and Ardais Launch Biorepository for Clinical Research in Cancer

 
Apr 15, 04

09:11 ET BioTrove, Inc. Completed a $13.7 Million Round of Financing With the Closing of a Second Traunch of $2.8 Million

 
Apr 14, 04

08:08 ET U.S. Genomics Licenses Locked Nucleic Acid (LNA (TM)) Chemistries from Exiqon

 
Apr 06, 04

08:05 ET Ardais Announces Expansion of Aventis Collaboration to Support Target Validation Efforts

 
Mar 25, 04

09:01 ET BioTrove Launches SNP Genotyping Capability -- The First Application of the Living Chip(TM) Nano-Fluidics Technology Platform

 
Mar 22, 04

09:22 ET BioTrove's Momentum Signs First Contract with Large Pharmaceutical Customer

 
Mar 11, 04

08:34 ET VaxInnate Corporation Raises $23.1 Million in Series B Financing

 
Mar 10, 04

10:59 ET Feinstein Kean Healthcare Program Wins Paul G. Rogers/NCPIE Medication Communicator Award

 
08:32 ET Scion Pharmaceuticals Announces Appointment of Valentin Gribkoff, Ph.D., as Vice President of Biology

 
Mar 09, 04

11:12 ET Scion Pharmaceuticals to Present at SG Cowen Health Care Conference

 
Feb 19, 04

08:01 ET Novartis Institutes for BioMedical Research Selects Feinstein Kean Healthcare as Agency of Record

 
Feb 02, 04

11:43 ET Icagen Raises $19.5 Million to Advance Ion Channel Drug Discovery And Development Programs

 
08:30 ET Icagen Raises $19.5 Million to Advance Ion Channel Drug Discovery and Development Programs

 
Dec 23, 03

16:01 ET Icagen Initiating Phase I Clinical Development Program for ICA-69673, a Novel Drug Candidate for Epilepsy

 
Dec 22, 03

08:31 ET Dynogen Pharmaceuticals, Inc. Enters into Agreement with Mitsubishi Pharma for Irritable Bowel Syndrome Compound

 
Dec 10, 03

08:10 ET Study Suggests RISPERDAL(R) CONSTA(TM), New Treatment For Schizophrenia, May Further Relieve Symptoms of Stable Patients

 
Dec 09, 03

08:00 ET Treating Schizophrenia Patients With RISPERDAL(R) CONSTA(R) May Reduce Hospitalization Rates And Cost Of Care

 
Dec 05, 03

08:00 ET FDA Approves Risperdal (R) for Treatment of Bipolar Mania

 
Dec 03, 03

15:58 ET Risperdal (R) Consta (R), First and Only Long-Acting, Newer-Generation Schizophrenia Treatment, Now Available

 
Nov 20, 03

14:01 ET Scientists Report on Promising New Approaches to Induce Cancer Cell Suicide

 
10:15 ET Three Molecular-Targeted Compounds Show Promise Against Cancers in Early Clinical Studies

 
08:30 ET Icagen and Abbott Laboratories Renew Drug Discovery Collaboration

 
Nov 19, 03

10:50 ET Scientists Discover Potential Approaches to Enhance Existing Cancer Therapies

 
10:49 ET Proteins May Help Identify Patients Who Will Respond Better to Different Treatments in Certain Cancers

 
10:47 ET New Drug Target and Biomarker for Advanced Childhood Cancer Discovered; Advances with Two Kinase Targets Reported

 
10:01 ET New Drug Target and Biomarker for Advanced Childhood Brain Cancer Discovered; Advances with Two Kinase Targets Reported

 
Nov 18, 03

12:47 ET Circadian Clock Genes May Provide Targets for New Cancer Drugs

 
Nov 13, 03

08:31 ET Nephros Therapeutics Appoints Richard Stead, MD as Chief Medical Officer and Karen Brennan as Senior Director of Clinical Operations

 
Nov 12, 03

11:27 ET Feinstein Kean Healthcare Expands Pharmaceutical and Consumer Health Practice Leadership

 
Nov 05, 03

09:30 ET Feinstein Kean Healthcare Wins Two 2003 Mature Media Awards

 
Nov 04, 03

09:45 ET Interim Results of Alzhemed(TM) Open-Label Phase II Extension Study Demonstrates Cognitive Benefits in Patients With Alzheimer's Disease

 
Oct 30, 03

08:05 ET FDA Approves RISPERDAL(R) CONSTA(TM) For Treating Schizophrenia

 
Oct 29, 03

19:10 ET FDA Approves RISPERDAL(R) CONSTA(TM) for Treating Schizophrenia

 
Sep 17, 03

08:32 ET Now Available, New Stalevo Addresses Top Parkinson's Disease Concern

 
Sep 10, 03

09:15 ET Feinstein Kean Healthcare Expands Pharmaceutical Communications Practice

 
08:31 ET Scion Announces Appointment of Ray Winquist, Ph.D., F.A.H.A., as Vice President of Pharmacology

 
Sep 09, 03

08:25 ET ArQule Completes Acquisition Of Cyclis Pharmaceuticals, An Ampersand Ventures' Portfolio Company

 
Sep 03, 03

08:03 ET Icagen Completes Patient Enrollment For Phase II Sickle Cell Anemia Clinical Trial

 
Aug 26, 03

09:15 ET First of its Kind Study Aims to Answer Important Questions About Girls and ADHD

 
Aug 22, 03

09:02 ET Data Show Exelon(R) Reduces Behavioral Disturbances Associated with Alzheimer's Disease

 
Aug 11, 03

08:06 ET BioTrove, Inc. Launches Momentum(TM) Technology - Ultra High-Throughput Mass Spectrometry System - For Functional Assay Development

 
Aug 07, 03

15:24 ET Trileptal(R) (oxcarbazepine) is Approved for Use as Monotherapy in Children With Epilepsy

 
Aug 01, 03

08:31 ET Jennifer Viera Joins Feinstein Kean Healthcare as Account Director

 
Jul 02, 03

15:05 ET Neurochem Clinical Advisory Board Recommends Initiation of Phase III For Alzhemed(TM)

 
09:04 ET Georges Haas, Ph.D. Joins Scion Pharmaceuticals' Board of Directors

 
Jun 23, 03

09:02 ET Neurochem Conference Call and Web Cast on Alzhemed(TM) Phase II Study for Alzheimer's Disease at 10:00 A.M. Et Today

 
08:25 ET Neurochem Reports Promising Findings From Alzhemed(TM) Phase II Study For Alzheimer's Disease

    
Jun 19, 03

09:00 ET Cyclis Provides Update on Research Programs and Business Activities at BIO 2003

 
Jun 13, 03